Abdi Ibrahim Ilac Sanayi ve Ticaret AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
22
About the Report
About the Report
Summary
Abdi Ibrahim Ilac Sanayi ve Ticaret AS (Abdi Ibrahim) is a pharmaceutical company which develops, manufactures, and markets original and generic prescription and non-prescription pharmaceutical products. Abdi Ibrahim's product portfolio includes antianemic drugs, antibacterial or antiviral drugs, cardiovascular system drugs, dermatologic products, endocrine and metabolism products, gastrointestinal agents, antihypertensive and antianginal drugs, nonsteroidal anti-inflammatory (NSAI) drugs, myorelaxants, ophthalmic agents, respiratory system and urogenital system medications, vitamins and minerals. The company established various joint investments and licensing agreements with leading pharmaceutical companies for the development and commercialization of its product portfolio. It markets and distributes its medications across Europe, CIS and Balkans, Middle East and North Africa, and Far East and Sub Saharan Africa. It manages a manufacturing facility, a logistics center, and a research and development center in Esenyurt, Istanbul. The company has operations in Algeria, Kazakhstan, Azerbaijan, Georgia and Iraq. Abdi Ibrahim is headquartered in Istanbul, Turkey.
Abdi Ibrahim Ilac Sanayi ve Ticaret AS-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Ocugen Raises USD7.5 Million in Series B Round of Funding 10
Partnerships 11
Abdi Ibrahim Enters into Distribution Agreement with Daewoong Pharma 11
Otsuka Pharma Forms Joint Venture With Abdi Ibrahim To Market Otsuka's Drugs In Turkey 12
Licensing Agreements 13
Abdi Ibrahim Enters Licensing Agreement with DEEF Pharma 13
Ilyang Pharma Enters into Licensing Agreement with Abdi Ibrahim 14
Ilyang Pharma Enters into Technology Licensing Agreement with Abdi Ibrahim 15
Abdi Ibrahim Enters into Licensing Agreement with Bosnalijek 16
Acquisition 17
Abdi Ibrahim Acquires 60% Stake In Global Pharm 17
Abdi Ibrahim Ilac Sanayi ve Ticaret AS-Key Competitors 18
Abdi Ibrahim Ilac Sanayi ve Ticaret AS-Key Employees 19
Abdi Ibrahim Ilac Sanayi ve Ticaret AS-Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Figure
List of Figures
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Deals By Therapy Area, 2012 to YTD 2018 8
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ocugen Raises USD7.5 Million in Series B Round of Funding 10
Abdi Ibrahim Enters into Distribution Agreement with Daewoong Pharma 11
Otsuka Pharma Forms Joint Venture With Abdi Ibrahim To Market Otsuka's Drugs In Turkey 12
Abdi Ibrahim Enters Licensing Agreement with DEEF Pharma 13
Ilyang Pharma Enters into Licensing Agreement with Abdi Ibrahim 14
Ilyang Pharma Enters into Technology Licensing Agreement with Abdi Ibrahim 15
Abdi Ibrahim Enters into Licensing Agreement with Bosnalijek 16
Abdi Ibrahim Acquires 60% Stake In Global Pharm 17
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Key Competitors 18
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Key Employees 19
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Other Locations 20
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Subsidiaries 21
Abdi Ibrahim Ilac Sanayi ve Ticaret AS, Joint Venture 21
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.